UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: July 30, 2015 (April 30, 2015)
Halyard Health, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-36440 | 46-4987888 | |
(State or other jurisdiction of incorporation) | (Commission file number) | (I.R.S. Employer Identification No.) | |
5405 Windward Parkway Suite 100 South Alpharetta, Georgia | 30004 | ||
(Address of principal executive offices) | (Zip code) | ||
Registrant’s telephone number, including area code: (678) 425-9273
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
Halyard Health, Inc. (the “Company”) previously disclosed in its current report on Form 8-K, filed on May 4, 2015, the voting results from its annual meeting held on April 30, 2015. The shareholders approved in a non-binding, advisory vote having a shareholder vote on the compensation of the Company’s executive officers every year. On July 30, 2015, the Company’s Board of Directors approved the Company’s adoption of the shareholder vote and shall each year (until the next required vote on the frequency of the compensation proposal) include a proposal in its proxy statement to approve the compensation of the named executive officers.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HALYARD HEALTH, INC. | ||||||
Date: August 5, 2015 | By: | /s/ S. Ross Mansbach | ||||
S. Ross Mansbach | ||||||
Vice President, Deputy General Counsel and Corporate Secretary | ||||||